Glutarate

Glutarate

SCHEMBL106537

O=C([O-])CCCC(=O)[O-].[Li+].[Li+]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Glutarate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.58
HDAC3 O15379 3/20 0.50
HDAC1 Q13547 3/20 0.50
HDAC2 Q92769 3/20 0.50
HDAC8 Q9BY41 3/20 0.50
FFAR3 O14843 2/20 0.50
BBOX1 O75936 3/20 0.46
CA4 P22748 2/20 0.44
FABP3 P05413 2/20 0.42
HDAC4 P56524 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
SLC22A6 Q4U2R8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutarate SCHEMBL107713 0.96 CA1 (0.55) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL8618874 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL8745235 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL3142994 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL11453115 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL5650126 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL2067310 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL5650130 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL5142628 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL5142631 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117039139-A Polymer electrolyte membrane, preparation method thereof and secondary battery 江苏清陶能源科技有限公司 2023-11-10 CN claimed
CN-114361456-B Water-based functional ion-conducting binder for lithium battery, preparation method and application 中国科学院化学研究所 2023-05-05 CN claimed
CN-113224386-B Cobalt acid lithium battery electrolyte additive, electrolyte and battery thereof 松山湖材料实验室 2022-07-22 CN claimed
CN-113224386-A Cobalt acid lithium battery electrolyte additive, electrolyte and battery thereof 松山湖材料实验室 2021-08-06 CN claimed
EP-2621012-B1 MANUFACTURING METHOD FOR ELECTROLYTE, ELECTROLYTE SOLUTION, GEL ELECTROLYTE, ELECTROLYTE MEMBRANE AND GEL ELECTROLYTE BATTERY, AND LITHIUM-ION SECONDARY BATTERY SEKISUI CHEMICAL CO LTD (JP) 2018-01-10 EP claimed
US-20260031400-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) 2026-01-29 US disclosed
CN-119816980-A Electrolyte for electric storage device, reinforcing agent, electrolyte solution, and electric storage device using same 富山药品工业株式会社 2025-04-11 CN disclosed
US-12269832-B2 Lithium borate compound, additive for lithium secondary battery, non-aqueous electrolyte solution for lithium secondary battery, lithium secondary battery precursor, and lithium secondary battery and method of producing the same MITSUI CHEMICALS, INC. (JP) 2025-04-08 US disclosed
EP-4525123-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME Tomiyama Pure Chemical Industries, Limited (JP) 2025-03-19 EP disclosed
EP-3771014-B1 NONAQUEOUS ELECTROLYTE SOLUTION FOR POWER STORAGE DEVICES TOMIYAMA PURE CHEMICAL INDUSTRIES LTD (JP) 2025-03-05 EP disclosed
US-12155037-B2 Nonaqueous electrolyte solution for power storage devices TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) 2024-11-26 US disclosed
US-20240376295-A1 TREATED INORGANIC PARTICLES FOR MODIFYING POLYMER CRYSTALLINITY THE CHEMOURS COMPANY FC, LLC (US) 2024-11-14 US disclosed
US-20070266622-A1 Fuel oil additive and fuel oil products containing said fuel oil additive JINZHOU SHENGTONG CHEMICAL CO., LTD. (CN) 2007-11-22 US disclosed
EP-1845132-A2 Silicon-containing film-forming composition, silicon-containing film, silicon-containing film-bearing substrate, and patterning method Shinetsu Chemical Co., Ltd. (JP) 2007-10-17 EP disclosed
US-20070238300-A1 Silicon-containing film-forming composition, silicon-containing film, silicon-containing film-bearing substrate, and patterning method SHIN-ETSU CHEMICAL CO., LTD. 2007-10-11 US disclosed
US-20040065002-A1 Fuel oil additive and fuel oil products containing the fuel oil additive HU SHIBIN (CN) 2004-04-08 US disclosed
CN-1380141-A Homogeneous carbonylation reaction catalyst and its preparation and application CHINESE ACAD INST CHEMISTRY (CN) 2002-11-20 CN disclosed
US-5463086-A Dissolving a crude lactide in a weak and strong solvent mixture then recrystallizing DAINIPPON INK AND CHEMICALS, INC. (JP) 1995-10-31 US disclosed
EP-0558311-A1 Light-sensitive lithographic printing plate KONICA CORPORATION (JP) 1993-09-01 EP disclosed
US-4490522-A REACTING POLYHALOGENATED AROMATIC COMPOUND WITH ALKALI METAL SULFIDE IN PRESENCE OF OXYALKYLENE COMPOUND DAINIPPON INK & CHEMICALS, INC. (JP) 1984-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12269832-B2 Lithium borate compound, additive for lithium secondary battery, non-aqueous electrolyte solution for lithium secondary battery, lithium secondary battery precursor, and lithium secondary battery and method of producing the same SLC9B2, LDHB, SLC26A3 CA1 732/4885HDAC3 1310/4885HDAC1 597/4885
US-20260031400-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME KCNN1, KCNN2, ILK CA1 588/4885HDAC3 4327/4885HDAC1 2563/4885
US-12155037-B2 Nonaqueous electrolyte solution for power storage devices AQP1, NCS1, SLC9A1 CA1 785/4885HDAC3 3581/4885HDAC1 2324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.